Drug that ‘melts away’ tumours hailed as ‘gamechanger’ for some bowel cancer patients
by Andrew Gregory Health editor in Chicago from Science | The Guardian on (#6N7S1)
Pembrolizumab triples chance of survival for the 10-15% of patients with the right genetic makeup, study finds
A gamechanger" immunotherapy drug that melts away" tumours dramatically increases the chances of curing some bowel cancers and may even replace the need for surgery, doctors have said.
Pembrolizumab targets and blocks a specific protein on the surface of immune cells that then seek out and destroy cancer cells.
Continue reading...